PIII — P3 Health Partners Cashflow Statement
0.000.00%
- $1.78bn
- $1.97bn
- $1.50bn
- 21
- 27
- 24
- 12
Annual cashflow statement for P3 Health Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -45.4 | -204 | -1,562 | -186 | -310 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | -12.4 | 53.4 | 1,313 | -6.69 | 27.3 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 32.4 | 75.8 | 35.2 | 30.4 | 88 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -24.6 | -66.5 | -126 | -76 | -110 |
Capital Expenditures | -2.93 | -3.41 | -2.23 | -1.83 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -0.24 | -52.7 | -5.5 | 0 | 14.5 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3.17 | -56.1 | -7.73 | -1.83 | 14.5 |
Financing Cash Flow Items | — | — | — | -0.364 | -0.68 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 34.8 | 223 | 11.4 | 100 | 98.8 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 7 | 101 | -122 | 22.5 | 3.17 |